These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25860784)

  • 1. Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120.
    Aneja R; Rashad AA; Li H; Kalyana Sundaram RV; Duffy C; Bailey LD; Chaiken I
    J Med Chem; 2015 May; 58(9):3843-58. PubMed ID: 25860784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
    Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM
    Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.
    Emileh A; Tuzer F; Yeh H; Umashankara M; Moreira DR; Lalonde JM; Bewley CA; Abrams CF; Chaiken IM
    Biochemistry; 2013 Apr; 52(13):2245-61. PubMed ID: 23470147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664.
    Acharya K; Rashad AA; Moraca F; Klasse PJ; Moore JP; Abrams C; Chaiken I
    Proteins; 2017 May; 85(5):843-851. PubMed ID: 28056499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy.
    Emileh A; Duffy C; Holmes AP; Rosemary Bastian A; Aneja R; Tuzer F; Rajagopal S; Li H; Abrams CF; Chaiken IM
    Biochemistry; 2014 Jun; 53(21):3403-14. PubMed ID: 24801282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Mol Graph Model; 2015 Sep; 61():262-71. PubMed ID: 26298811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols.
    Bailey LD; Kalyana Sundaram RV; Li H; Duffy C; Aneja R; Rosemary Bastian A; Holmes AP; Kamanna K; Rashad AA; Chaiken I
    ACS Chem Biol; 2015 Dec; 10(12):2861-73. PubMed ID: 26458166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-natural peptide triazole antagonists of HIV-1 envelope gp120.
    Kamanna K; Aneja R; Duffy C; Kubinski P; Rodrigo Moreira D; Bailey LD; McFadden K; Schön A; Holmes A; Tuzer F; Contarino M; Freire E; Chaiken IM
    ChemMedChem; 2013 Feb; 8(2):322-8. PubMed ID: 23239505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
    Umashankara M; McFadden K; Zentner I; Schön A; Rajagopal S; Tuzer F; Kuriakose SA; Contarino M; Lalonde J; Freire E; Chaiken I
    ChemMedChem; 2010 Nov; 5(11):1871-9. PubMed ID: 20677318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
    Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
    J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism.
    Tuzer F; Madani N; Kamanna K; Zentner I; LaLonde J; Holmes A; Upton E; Rajagopal S; McFadden K; Contarino M; Sodroski J; Chaiken I
    Proteins; 2013 Feb; 81(2):271-90. PubMed ID: 23011758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
    Gopi H; Umashankara M; Pirrone V; LaLonde J; Madani N; Tuzer F; Baxter S; Zentner I; Cocklin S; Jawanda N; Miller SR; Schön A; Klein JC; Freire E; Krebs FC; Smith AB; Sodroski J; Chaiken I
    J Med Chem; 2008 May; 51(9):2638-47. PubMed ID: 18402432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
    Chaiken I; Rashad AA
    Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 16. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
    Gopi H; Cocklin S; Pirrone V; McFadden K; Tuzer F; Zentner I; Ajith S; Baxter S; Jawanda N; Krebs FC; Chaiken IM
    J Mol Recognit; 2009; 22(2):169-74. PubMed ID: 18498083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restraining the conformation of HIV-1 gp120 by removing a flexible loop.
    Rits-Volloch S; Frey G; Harrison SC; Chen B
    EMBO J; 2006 Oct; 25(20):5026-35. PubMed ID: 17006538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring.
    Rashad AA; Acharya K; Haftl A; Aneja R; Dick A; Holmes AP; Chaiken I
    Org Biomol Chem; 2017 Sep; 15(37):7770-7782. PubMed ID: 28770939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
    Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
    Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.